Left Atrial Appendage Closure: Effective to Reduce Risk of Stroke?

Original Title: Effectiveness of Left Atrial Appendage Exclusion Procedures to Reduce the Risk of Stroke: A Systematic Review of the Evidence.

Reference: North Noelck et al. Circ Cardiovasc Qual Outcomes. July 2016. Published ahead of print.

 
Left Atrial Appendage ClosureAtrial fibrillation is an important cause of stroke. Oral anticoagulation reduces the risk of stroke but, on the other hand, increases the risk of bleeding. Left atrial appendage closure procedures have been designed to isolate the left atrial appendage (LAA) from blood circulation and is an alternative to oral anticoagulation.

This study is a systematic review to assess the risks and benefits of percutaneous or surgical LAA closure.

In all, 20 studies met the pre-specified inclusion criteria, from where researchers recovered patient characteristics, and stroke, mortality and adverse events rates.  The quality and state of evidence were also assessed according to publication criteria.

Researchers found studies with low quality evidence concluding LAA closure and anticoagulation had similar risk of stroke and mortality rates, noting, however, this evidence was limited to Watchman implantation in patients eligible for oral anticoagulation at short term.

Observational studies provide stronger evidence on the possibility of periprocedural adverse events after percutaneous LAA closure with practically all available devices.

There is little evidence on surgical LAA closure in the context of heart surgery for another indication (either cardiac or vascular), but it doesn’t seem to contribute to surgery-related adverse events that. There is insufficient data to argue that surgery will reduce stroke risk.

 

Conclusion

There is limited evidence to support the Watchman might be superior to long term oral anticoagulation in selected patients. There is not enough data on the effectiveness of different devices in patients who are ineligible for oral anticoagulation. Percutaneous LAA closure is associated with a relatively high risk of periprocedural complications.

 

We value your opinion. You are more than welcome to leave your comments, thoughts, questions or suggestions here below.

More articles by this author

One-Year Results of ENCIRCLE: Percutaneous Mitral Valve Replacement in Patients Ineligible for Surgery or TEER

Symptomatic mitral regurgitation (MR) in patients who are not candidates for surgery or transcatheter edge-to-edge repair (TEER) remains a highly complex clinical scenario associated...

Can Coronary CT Angiography Replace Invasive Coronary Angiography in Pre-TAVI Coronary Assessment?

Coronary artery disease coexists in approximately half of patients undergoing transcatheter aortic valve implantation, making coronary assessment prior to the procedure essential. Invasive coronary...

Valve-in-Valve in Small Surgical Aortic Bioprostheses: Balloon-Expandable or Self-Expanding? Three-Year Results from the LYTEN Trial

Dysfunction of small surgical aortic bioprostheses represents a challenging scenario for transcatheter aortic valve replacement in the valve-in-valve setting, due to the higher incidence...

Can TAVI Be Safely Performed in Patients With Bicuspid Aortic Valve?

Bicuspid aortic valve (BAV) represents an anatomical challenge for transcatheter aortic valve replacement (TAVR) due to the frequent presence of elliptical annuli, fibroc calcific...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

One-Year Results of ENCIRCLE: Percutaneous Mitral Valve Replacement in Patients Ineligible for Surgery or TEER

Symptomatic mitral regurgitation (MR) in patients who are not candidates for surgery or transcatheter edge-to-edge repair (TEER) remains a highly complex clinical scenario associated...

Can Coronary CT Angiography Replace Invasive Coronary Angiography in Pre-TAVI Coronary Assessment?

Coronary artery disease coexists in approximately half of patients undergoing transcatheter aortic valve implantation, making coronary assessment prior to the procedure essential. Invasive coronary...

Valve-in-Valve in Small Surgical Aortic Bioprostheses: Balloon-Expandable or Self-Expanding? Three-Year Results from the LYTEN Trial

Dysfunction of small surgical aortic bioprostheses represents a challenging scenario for transcatheter aortic valve replacement in the valve-in-valve setting, due to the higher incidence...